The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 17, 2018

Filed:

May. 24, 2011
Applicants:

Lin Ji, Sugar Land, TX (US);

John Dorrance Minna, Dallas, TX (US);

Jack Roth, Houston, TX (US);

Michael Lerman, Rockville, MD (US);

Inventors:

Lin Ji, Sugar Land, TX (US);

John Dorrance Minna, Dallas, TX (US);

Jack Roth, Houston, TX (US);

Michael Lerman, Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); A61K 48/00 (2006.01); A01K 67/027 (2006.01); C07K 14/47 (2006.01); C12N 15/85 (2006.01); C12Q 1/68 (2018.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A01K 67/0271 (2013.01); A01K 67/0275 (2013.01); A61K 48/00 (2013.01); C07K 14/4703 (2013.01); C12N 15/8509 (2013.01); C12Q 1/6886 (2013.01); A01K 2217/05 (2013.01); A01K 2217/075 (2013.01); A01K 2217/20 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0331 (2013.01); C12N 2710/10343 (2013.01); C12N 2830/006 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/154 (2013.01); Y10S 977/916 (2013.01);
Abstract

Tumor suppressor genes play a major role in the pathogenesis of human lung cancer and other cancers. Cytogenetic and allelotyping studies of fresh tumor and tumor-derived cell lines showed that cytogenetic changes and allele loss on the short arm of chromosome 3 (3p) are most frequently involved in about 90% of small cell lung cancers and greater than 50% of non-small cell lung cancers. A group of recessive oncogenes, Fus1, 101F6, Gene 21 (NPRL2), Gene 26 (CACNA2D2), Luca 1 (HYAL1), Luca 2 (HYAL2), PL6, 123F2 (RaSSFI), SEM A3 and Beta* (BLU), as defined by homozygous deletions in lung cancers, have been located and isolated at 3p21.3.


Find Patent Forward Citations

Loading…